Business Context and Reporting Period
This Form 6-K filing by pSivida Limited (a foreign issuer) covers the month of April 2007, with the report dated April 13, 2007. The registrant is based in Perth, Western Australia, and files annual reports on Form 20-F. The filing incorporates by reference an ASX release regarding the sale of a subsidiary.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves primarily as a notice of a corporate transaction rather than a financial results report.
Material Changes
The primary material change disclosed is the sale of the AION Diagnostics subsidiary, as detailed in the attached Exhibit 99.1 (ASX Release). No other material changes to financial position or operations are quantified in the provided text.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or specific risk factors beyond the disclosure of the subsidiary sale. The document incorporates the sale announcement into several existing Registration Statements on Form F-3.
Investor Verification Checklist
- Verify the terms and financial impact of the AION Diagnostics subsidiary sale in the full ASX release (Exhibit 99.1).
- Confirm the status of the five referenced Form F-3 registration statements (Nos. 333-132776, 333-132777, 333-135428, 333-141083, and 333-141091).
- Review subsequent filings for updated financial statements reflecting the divestiture.